HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shunsuke Hamada Selected Research

Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)

8/2017Immunohistochemical staining with non-phospho β-catenin as a diagnostic and prognostic tool of COX-2 inhibitor therapy for patients with extra-peritoneal desmoid-type fibromatosis.
12/2015Low-dose chemotherapy with methotrexate and vinblastine for patients with desmoid tumors: relationship to CTNNB1 mutation status.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shunsuke Hamada Research Topics

Disease

14Aggressive Fibromatosis (Desmoid)
01/2022 - 01/2014
12Neoplasms (Cancer)
01/2021 - 01/2014
9Fibroma (Fibromatosis)
01/2022 - 08/2017
4Neoplasm Metastasis (Metastasis)
01/2017 - 08/2014
3Neurofibrosarcoma (MPNST)
01/2021 - 08/2014
2Crohn Disease (Crohn's Disease)
02/2020 - 01/2018
2Chondrosarcoma
01/2020 - 01/2018
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
10/2019 - 01/2018
1Diabetes Mellitus
02/2022
1Breast Neoplasms (Breast Cancer)
01/2021
1Neutropenia
01/2021
1Osteoporosis
01/2021
1Pain (Aches)
04/2020
1Body Weight (Weight, Body)
02/2020
1Leukopenia
10/2019
1Osteoarthritis
01/2017
1Pigmented Villonodular Synovitis
07/2015
1Disease Progression
07/2015
1Hyperthermia
02/2015
1Osteosarcoma (Osteogenic Sarcoma)
06/2014

Drug/Important Bio-Agent (IBA)

8CateninsIBA
11/2020 - 01/2014
6Meloxicam (Mobic)FDA LinkGeneric
12/2019 - 01/2014
4Hyaluronic Acid (Hyaluronan)IBA
01/2020 - 08/2014
3Vinblastine (Vinblastine Sulfate)FDA Link
11/2020 - 12/2015
3Methotrexate (Mexate)FDA LinkGeneric
11/2020 - 12/2015
3Pharmaceutical PreparationsIBA
09/2020 - 01/2018
2AlbuminsIBA
02/2020 - 01/2017
2Infliximab (Remicade)FDA Link
02/2020 - 01/2018
2Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
01/2020 - 01/2017
2HymecromoneIBA
01/2018 - 01/2017
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
08/2017 - 12/2015
2Proteins (Proteins, Gene)FDA Link
07/2015 - 08/2014
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
05/2014 - 01/2014
1Auranofin (Ridaura)FDA Link
01/2022
1pazopanibFDA Link
01/2021
1Diphosphonates (Bisphosphonates)IBA
01/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021
1Lipase (Acid Lipase)FDA Link
01/2021
1SteroidsIBA
01/2021
1Therapeutic UsesIBA
09/2020
1Alcian BlueIBA
01/2020
1NucleosidesIBA
10/2019
1Diphosphates (Pyrophosphates)IBA
10/2019
12-mercaptopurineIBA
10/2019
1Biological ProductsIBA
06/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018
1Carrier Proteins (Binding Protein)IBA
01/2017
1Protons (Proton)IBA
12/2016
1Macrophage Colony-Stimulating FactorIBA
07/2015
1Ferrosoferric Oxide (Magnetite)FDA Link
02/2015
1Liposomes (Liposome)IBA
02/2015
1AlginatesIBA
02/2015
1Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
06/2014
1Matrix Metalloproteinases (MMPs)IBA
06/2014

Therapy/Procedure

7Therapeutics
01/2020 - 01/2014
5Drug Therapy (Chemotherapy)
01/2021 - 12/2015
4Conservative Treatment
11/2021 - 01/2014
1Treatment Delay
02/2022
1Molecular Targeted Therapy
01/2022
1Activities of Daily Living (ADL)
11/2021
1Radiotherapy
12/2016